Myokinasib-II

• UNSPSC Description:

  Myokinasib-II is a myosin light chain kinase (MLCK) inhibitor, which is a potential target for inflammatory diseases, cancer and other diseases.[1].

• Target Antigen:

  Myosin

• Type:

  Reference compound

• Related Pathways:

  Cytoskeleton

• Applications:

  Cancer-programmed cell death

• Field of Research:

  Cancer

• Assay Protocol:

  https://www.medchemexpress.com/myokinasib-ii.html

• Smiles:

  O=C(C1(C(C2=CC=C(F)C=C2C)C([N+]([O-])=O)C3(C)N1)CC4=C3NC5=C4C=CC=C5)OCC

• Molecular Weight:

  437.46

• References & Citations:

  [1]Kumar G, et al. Identification and Benchmarking of Myokinasib-II as a Selective and Potent Chemical Probe for Exploring MLCK1 Inhibition. ACS Chem Biol. 2024 Oct 18;19(10):2165-2175.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported